Anne Whitaker has extensive life sciences industry experience, having worked across the pharmaceutical, biotech and specialty pharma sectors for the last thirty years in the US and internationally.
Anne previously held a number of senior executive roles at Sanofi, GlaxoSmithKline, Bausch Health Company and Synta Pharmaceuticals, and most recently, she held the position of Chief Executive Officer, and subsequently Chairperson of Aerami Therapeutics, a private life science company. She has served as a Non-Executive Director at a number of UK-listed healthcare / pharmaceutical services companies including UDG Healthcare and Vectura Group and is currently on the board of a number of global biopharmaceutical companies.
Anne is recognised as a biopharma industry influencer, advisor and leader, having received numerous awards from PharmaVoice, WomenInc and Fierce Pharma. She holds a BSc in Chemistry and Business from the University of North Alabama.
Anne is a member of Ergomed’s Nomination Committee.
